132 related articles for article (PubMed ID: 22326625)
1. Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells.
Bassoy EY; Baran Y
Biomed Pharmacother; 2012 Mar; 66(2):103-10. PubMed ID: 22326625
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
Kartal M; Saydam G; Sahin F; Baran Y
Nutr Cancer; 2011; 63(4):637-44. PubMed ID: 21500096
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
Gencer EB; Ural AU; Avcu F; Baran Y
Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
[TBL] [Abstract][Full Text] [Related]
5. The roles of antiapoptotic sphingosine kinase-1 and glucosylceramide genes in drug induced cell death of MCF-7 breast cancer cells.
Gucluler G; Piskin O; Baran Y
J BUON; 2011; 16(4):646-51. PubMed ID: 22331716
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
[TBL] [Abstract][Full Text] [Related]
7. Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells.
Camgoz A; Gencer EB; Ural AU; Avcu F; Baran Y
Leuk Lymphoma; 2011 Aug; 52(8):1574-84. PubMed ID: 21756066
[TBL] [Abstract][Full Text] [Related]
8. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
[TBL] [Abstract][Full Text] [Related]
9. Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells.
Kimura K; Markowski M; Edsall LC; Spiegel S; Gelmann EP
Cell Death Differ; 2003 Feb; 10(2):240-8. PubMed ID: 12700652
[TBL] [Abstract][Full Text] [Related]
10. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
Van Brocklyn JR; Williams JB
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.
Pchejetski D; Kunduzova O; Dayon A; Calise D; Seguelas MH; Leducq N; Seif I; Parini A; Cuvillier O
Circ Res; 2007 Jan; 100(1):41-9. PubMed ID: 17158340
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
Yoo J; Park SS; Lee YJ
J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
14. First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer.
Brizuela L; Ader I; Mazerolles C; Bocquet M; Malavaud B; Cuvillier O
Mol Cancer Ther; 2012 Sep; 11(9):1841-51. PubMed ID: 22784711
[TBL] [Abstract][Full Text] [Related]
15. KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.
Mavridis K; Talieri M; Scorilas A
Biol Chem; 2010 Apr; 391(4):467-74. PubMed ID: 20128692
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells.
Karabulut B; Erten C; Gul MK; Cengiz E; Karaca B; Kucukzeybek Y; Gorumlu G; Atmaca H; Uzunoglu S; Sanli UA; Baran Y; Uslu R
Cell Biol Int; 2009 Feb; 33(2):239-46. PubMed ID: 19103299
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells.
Nava VE; Cuvillier O; Edsall LC; Kimura K; Milstien S; Gelmann EP; Spiegel S
Cancer Res; 2000 Aug; 60(16):4468-74. PubMed ID: 10969794
[TBL] [Abstract][Full Text] [Related]
18. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase-1--a potential therapeutic target in cancer.
Cuvillier O
Anticancer Drugs; 2007 Feb; 18(2):105-10. PubMed ID: 17159597
[TBL] [Abstract][Full Text] [Related]
20. The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.
Cakir Z; Saydam G; Sahin F; Baran Y
J Cancer Res Clin Oncol; 2011 Feb; 137(2):279-86. PubMed ID: 20401667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]